Osborn Williams & Donohoe’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-8,000
| Closed | -$220K | – | 312 |
|
|
2019
Q3 | $220K | Hold |
8,000
| – | – | 0.02% | 296 |
|
|
2019
Q2 | $265K | Hold |
8,000
| – | – | 0.03% | 285 |
|
|
2019
Q1 | $306K | Hold |
8,000
| – | – | 0.03% | 294 |
|
|
2018
Q4 | $266K | Hold |
8,000
| – | – | 0.05% | 194 |
|
|
2018
Q3 | $403K | Hold |
8,000
| – | – | 0.06% | 184 |
|
|
2018
Q2 | $479K | Hold |
8,000
| – | – | 0.08% | 163 |
|
|
2018
Q1 | $366K | Hold |
8,000
| – | – | 0.06% | 175 |
|
|
2017
Q4 | $319K | Sell |
8,000
-1,000
| -11% | -$39.9K | 0.05% | 188 |
|
|
2017
Q3 | $360K | Hold |
9,000
| – | – | 0.06% | 175 |
|
|
2017
Q2 | $388K | Hold |
9,000
| – | – | 0.07% | 169 |
|
|
2017
Q1 | $282K | Hold |
9,000
| – | – | 0.05% | 188 |
|
|
2016
Q4 | $227K | Hold |
9,000
| – | – | 0.04% | 200 |
|
|
2016
Q3 | $223K | Buy |
+9,000
| New | +$223K | 0.04% | 204 |
|